Kurzweil Scorecard: The Meat Grew. The Market Starved.

In 2005, Ray Kurzweil made a quiet bet buried in a chapter about ending world hunger: that we would learn to grow meat in factories from cultured animal cells, that this would make protein “extremely inexpensive,” and that it would therefore wipe out both animal suffering and the ecological wreckage of industrial farming. He framed it as an information-technology story — meat becoming software, subject to the same deflation that took a megabyte from a fortune to a rounding error.

Twenty-one years later, the strangest thing about this prediction is how literally it came true at the bench and how completely it failed everywhere else. We can grow a chicken breast without a chicken. Five companies have U.S. regulatory clearance to sell it. And the industry that does it is, as of mid-2026, in something close to free fall — not because the science broke, but because the economics and the politics did. Kurzweil predicted the biology. He missed the bankruptcy.

The predictions

All three predictions in this batch come from the same chapter, Solving World Hunger (The Singularity Is Near, 2005). They form a dependency chain.

The foundation: cloning animal muscle tissue in factories, without whole animals, will provide a possible solution to world hunger by creating extremely low-cost meat (ch. “Solving World Hunger”). Built on top of it: animal-less meat and cloned by-products like leather and fur will eliminate animal suffering and reduce both ecological damage and prion-disease risk from factory farming. And the engine underneath both: animal-less meat production will fall under the law of accelerating returns, and therefore become extremely inexpensive over time.

Kurzweil never softened the claim. In The Singularity Is Nearer (2024) he doubled down: “meat grown cleanly and ethically from cell cultures will displace environmentally devastating factory farming.” He cited the toll he expected it to end — “In 2020 humans slaughtered more than 74 billion land animals for meat” — and conceded only a timing wrinkle: “As of 2023 the technology can replicate meats without much structure, like the texture of ground beef, but it isn’t yet ready to generate full filet mignon steaks from scratch.”

That filet-mignon hedge turns out to be the least of the problem.

Where we actually are

The mechanism is real, and the patents read like Kurzweil’s recipe. This is not vaporware. US 11,981,884, granted to Upside Foods in May 2024, claims a “pipe-based bioreactor” — an elongated cylindrical vessel between 4 and 25 inches across, packed with rotatable substrates that meat cells adhere to on both faces, driven by magnetic couplings so the vessel itself never has to spin. It is, in plain English, an industrial pipe you grow muscle inside. US 12,031,152 claims an “edible nutrient medium for the production of slaughter-free meat” built from defined growth factors — IGF-1, FGF-1, FGF-2, PDGF, EGF, VEGF and others — explicitly engineered to drop the toxic trace salts you’d never want in food. And US 12,349,704 claims cultured meat seeded from induced pluripotent stem cells or satellite cells, dosed with natural colorant, vitamin B12 and iron to fix the pallor and nutritional gaps of meat that never saw a bloodstream. Read together, these three patents are a near-verbatim implementation of “clone the muscle tissue in a factory.” Kurzweil got the biology right.

The patent record shows the field arriving on schedule. Filings mentioning cultured or cell-based meat were a trickle through the 2010s, then jumped — 16 in 2024, 14 in 2025 by our count, with Upside Foods, Aleph Farms, and the company formerly called Memphis Meats among the named assignees. The science is even louder: papers on cultivated meat and cellular agriculture went from 17 in 2013 — the year Mark Post unveiled the first lab-grown burger — to 572 in 2024. The 2013 burger cost roughly $330,000 to produce, funded by Sergey Brin. That number is the key to everything that follows.

The cost curve is the part Kurzweil nailed. From $330,000 per patty in 2013 to a credible $3.43 per pound today is a collapse of roughly five orders of magnitude in a dozen years. In March 2025, Aleph Farms reported production costs below $10 a pound. French firm Gourmey had an independent techno-economic review by Arthur D. Little confirm a path to $3.43 per pound — about €7 per kilogram — in a 5,000-liter system. If you only looked at the slope, you would conclude the law of accelerating returns is alive and well, and that the prediction is simply mid-curve.

But the destination Kurzweil promised — cheap protein that ends hunger — is exactly where the story breaks. A widely cited 2021 techno-economic analysis by David Humbird, published in Biotechnology and Bioengineering, took the fermentation and biopharma playbook and applied it cold to animal cells. Its conclusions are brutal and specific: low growth rates, metabolic inefficiency, catabolite inhibition, and shear-induced cell damage all cap how big and how dense a bioreactor can run; contamination safeguards drive capital costs up; pharma-grade amino acids and growth factors are expensive. The paper concludes that the economics “would likely preclude the affordability of their products as food,” and that cheaper plant-hydrolysate media and metabolic improvements are “both necessary but insufficient” to displace conventional meat. The most-cited literature in this field, it turns out, is not breakthrough announcements — it’s review after review on consumer acceptance, perceived disgust, scale-up economics, and a 2020 paper bluntly titled The Myth of Cultured Meat. The discourse is about whether this works at all, not how fast it’s winning.

And then came the obstacle Kurzweil’s framework had no slot for: people voted against it. As of mid-2026, seven U.S. states — Alabama, Florida, Indiana, Mississippi, Montana, Nebraska, and Texas — have banned the sale of cultivated meat outright. Texas signed its ban in June 2025. Upside Foods, a company with full federal approval to sell, is now suing Florida for the right to sell a product the FDA and USDA already cleared. A technology Kurzweil assumed would diffuse on pure economic gravity is being legislated out of existence in the states with the most cattle.

The capital agreed with the skeptics before the voters did. Sector funding peaked near $1 billion in 2021, then fell to roughly $177 million in 2023, $55 million in 2024, and about $65 million in 2025 — a collapse of more than 90%. In late 2025, two of the field’s marquee names folded within days of each other. Believer Meats — which had completed the U.S. regulatory path and built what was billed as the world’s largest cultivated-meat facility, capable of 12,000 tonnes a year — ceased operations after raising nearly $400 million. Meatable, a Dutch pork startup named to Time’s best inventions of 2024, shut down for lack of funding. CellRev, Upstream Foods, and SCiFi Foods went the same way. Upside Foods paused its large-scale Illinois plant. The single biggest cultivated-meat sales event to date was a few packages of pork meatballs at one Berkeley grocery store in November 2025. Against 74 billion animals slaughtered a year, the suffering averted so far rounds to zero.

The scorecard

What Kurzweil missed (and what he nailed)

The pattern in this batch is unusually clean, and it exposes a specific blind spot in accelerating-returns thinking. Kurzweil was right about the hard part — the biology. We genuinely can clone muscle tissue in a pipe and feed it defined growth factors instead of fetal calf serum. He was even right about the cost curve, which fell like clockwork from a Brin-funded $330,000 novelty toward single-digit dollars. If technology were the only variable, this prediction would be cruising.

But the law of accelerating returns is a statement about engineering, and it quietly assumes the capital and the permission to keep climbing the curve. Cultivated meat ran out of both at once. The money that funds each doubling evaporated when investors read the same techno-economic math the academics published, and the social license evaporated when cattle states realized what was coming. Kurzweil’s framework has no term for a legislature, and no term for a venture market that simply stops believing. The meat grew exactly as predicted. The market it was supposed to feed never showed up to eat.

Method note

This scorecard draws on a full-text search of roughly 9.3 million U.S. patents and 357 million scientific papers in our research index — used to trace filing and publication trends and to read the actual claims of key cultivated-meat patents — plus current web reporting on regulatory approvals, state legislation, production costs, and company closures. Every figure here comes from a patent we read, a paper we pulled, or a dated source we accessed this week. Predictions are quoted from The Singularity Is Near (2005) and The Singularity Is Nearer (2024).